Shorter treatment with hepatitis C drug combination may be more beneficial, study shows

University of Cincinnati research published in the Sept. 14, 2011, advance online edition of the New England Journal of Medicine shows that patients with hepatitis C who took a combination medication—a telaprevir-based regimen that is commonly used to treat the illness—for 24 weeks were cured.

Read the whole article on Physorg

More from Physorg